{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T13:48:36Z","timestamp":1793713716840,"version":"4.6.1"},"reference-count":132,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Russsian Science Foundation","award":["#24-25-00161"],"award-info":[{"award-number":["#24-25-00161"]}],"id":[{"id":"https:\/\/ror.org\/03y2gwe85","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Direct"],"DOI":"10.1186\/s13062-025-00604-3","type":"journal-article","created":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T13:44:13Z","timestamp":1742478253000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Dualistic role of ZEB1 and ZEB2 in tumor progression"],"prefix":"10.1186","volume":"20","author":[{"given":"Sergey E.","family":"Parfenyev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra A.","family":"Daks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleg Y.","family":"Shuvalov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga A.","family":"Fedorova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolay B.","family":"Pestov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyana V.","family":"Korneenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nickolai A.","family":"Barlev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,20]]},"reference":[{"key":"604_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","volume":"166","author":"MA Nieto","year":"2016","unstructured":"Nieto MA, Huang RY-J, Jackson RA, Thiery JP. EMT: 2016. Cell. 2016;166:21\u201345.","journal-title":"Cell"},{"key":"604_CR2","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s00018-008-8465-8","volume":"66","author":"C Vandewalle","year":"2009","unstructured":"Vandewalle C, Van Roy F, Berx G. The role of the ZEB family of transcription factors in development and disease. Cell Mol Life Sci. 2009;66:773\u201387.","journal-title":"Cell Mol Life Sci"},{"key":"604_CR3","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrm1835","volume":"7","author":"JP Thiery","year":"2006","unstructured":"Thiery JP, Sleeman JP. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol. 2006;7:131\u201342.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"604_CR4","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1002\/1878-0261.12098","volume":"11","author":"A Katsura","year":"2017","unstructured":"Katsura A, Tamura Y, Hokari S, Harada M, Morikawa M, Sakurai T, et al. ZEB1-regulated inflammatory phenotype in breast cancer cells. Mol Oncol. 2017;11:1241\u201362.","journal-title":"Mol Oncol"},{"key":"604_CR5","doi-asserted-by":"publisher","first-page":"e86","DOI":"10.15190\/d.2018.7","volume":"6","author":"M Madany","year":"2018","unstructured":"Madany M, Thomas T, Edwards LA. The curious case of ZEB1. Discoveries (Craiova). 2018;6:e86.","journal-title":"Discoveries (Craiova)"},{"key":"604_CR6","doi-asserted-by":"publisher","first-page":"5073","DOI":"10.1093\/emboj\/18.18.5073","volume":"18","author":"JE Remacle","year":"1999","unstructured":"Remacle JE, Kraft H, Lerchner W, Wuytens G, Collart C, Verschueren K, et al. New mode of DNA binding of multi-zinc finger transcription factors: deltaEF1 family members bind with two hands to two target sites. EMBO J. 1999;18:5073\u201384.","journal-title":"EMBO J"},{"key":"604_CR7","doi-asserted-by":"publisher","first-page":"20489","DOI":"10.1074\/jbc.274.29.20489","volume":"274","author":"K Verschueren","year":"1999","unstructured":"Verschueren K, Remacle JE, Collart C, Kraft H, Baker BS, Tylzanowski P, et al. SIP1, a novel zinc finger\/homeodomain repressor, interacts with Smad proteins and binds to 5\u2019-CACCT sequences in candidate target genes. J Biol Chem. 1999;274:20489\u201398.","journal-title":"J Biol Chem"},{"key":"604_CR8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.pneurobio.2015.07.001","volume":"132","author":"SV Hegarty","year":"2015","unstructured":"Hegarty SV, Sullivan AM, O\u2019Keeffe GW. Zeb2: a multifunctional regulator of nervous system development. Prog Neurobiol. 2015;132:81\u201395.","journal-title":"Prog Neurobiol"},{"key":"604_CR9","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1093\/hmg\/ddn007","volume":"17","author":"G Verstappen","year":"2008","unstructured":"Verstappen G, van Grunsven LA, Michiels C, Van de Putte T, Souopgui J, Van Damme J, et al. Atypical Mowat-Wilson patient confirms the importance of the novel association between ZFHX1B\/SIP1 and NuRD corepressor complex. Hum Mol Genet. 2008;17:1175\u201383.","journal-title":"Hum Mol Genet"},{"key":"604_CR10","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1242\/dev.083105","volume":"140","author":"N Reynolds","year":"2013","unstructured":"Reynolds N, O\u2019Shaughnessy A, Hendrich B. Transcriptional repressors: multifaceted regulators of gene expression. Development. 2013;140:505\u201312.","journal-title":"Development"},{"key":"604_CR11","doi-asserted-by":"publisher","first-page":"921564","DOI":"10.1155\/2014\/921564","volume":"2014","author":"T-S Wong","year":"2014","unstructured":"Wong T-S, Gao W, Chan JY-W. Transcription regulation of E-cadherin by zinc finger E-box binding homeobox proteins in solid tumors. Biomed Res Int. 2014;2014:921564.","journal-title":"Biomed Res Int"},{"key":"604_CR12","doi-asserted-by":"crossref","unstructured":"Peinado H, Olmeda D, Cano A, Snail. Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer. 2007;7:415\u201328.","DOI":"10.1038\/nrc2131"},{"key":"604_CR13","doi-asserted-by":"publisher","first-page":"6683","DOI":"10.1073\/pnas.96.12.6683","volume":"96","author":"AA Postigo","year":"1999","unstructured":"Postigo AA, Dean DC. ZEB represses transcription through interaction with the corepressor CtBP. Proc Natl Acad Sci U S A. 1999;96:6683\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"604_CR14","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0014-5793(98)00588-2","volume":"429","author":"A Sundqvist","year":"1998","unstructured":"Sundqvist A, Sollerbrant K, Svensson C. The carboxy-terminal region of adenovirus E1A activates transcription through targeting of a C-terminal binding protein-histone deacetylase complex. FEBS Lett. 1998;429:183\u20138.","journal-title":"FEBS Lett"},{"key":"604_CR15","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1093\/emboj\/cdg225","volume":"22","author":"AA Postigo","year":"2003","unstructured":"Postigo AA. Opposing functions of ZEB proteins in the regulation of the TGFbeta\/BMP signaling pathway. EMBO J. 2003;22:2443\u201352.","journal-title":"EMBO J"},{"key":"604_CR16","doi-asserted-by":"publisher","first-page":"e76733","DOI":"10.1371\/journal.pone.0076733","volume":"8","author":"A Conidi","year":"2013","unstructured":"Conidi A, van den Berghe V, Leslie K, Stryjewska A, Xue H, Chen Y-G, et al. Four amino acids within a tandem QxVx repeat in a predicted extended \u03b1-helix of the smad-binding domain of Sip1 are necessary for binding to activated smad proteins. PLoS ONE. 2013;8:e76733.","journal-title":"PLoS ONE"},{"key":"604_CR17","doi-asserted-by":"publisher","first-page":"10498","DOI":"10.1038\/ncomms10498","volume":"7","author":"W Lehmann","year":"2016","unstructured":"Lehmann W, Mossmann D, Kleemann J, Mock K, Meisinger C, Brummer T, et al. ZEB1 turns into a transcriptional activator by interacting with YAP1 in aggressive cancer types. Nat Commun. 2016;7:10498.","journal-title":"Nat Commun"},{"key":"604_CR18","doi-asserted-by":"publisher","first-page":"3490","DOI":"10.1038\/onc.2010.102","volume":"29","author":"E S\u00e1nchez-Till\u00f3","year":"2010","unstructured":"S\u00e1nchez-Till\u00f3 E, L\u00e1zaro A, Torrent R, Cuatrecasas M, Vaquero EC, Castells A, et al. ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI\/SNF chromatin-remodeling protein BRG1. Oncogene. 2010;29:3490\u2013500.","journal-title":"Oncogene"},{"key":"604_CR19","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1002\/dvdy.20727","volume":"235","author":"LA van Grunsven","year":"2006","unstructured":"van Grunsven LA, Taelman V, Michiels C, Opdecamp K, Huylebroeck D, Bellefroid EJ. deltaEF1 and SIP1 are differentially expressed and have overlapping activities during Xenopus embryogenesis. Dev Dyn. 2006;235:1491\u2013500.","journal-title":"Dev Dyn"},{"key":"604_CR20","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.3390\/genes12071037","volume":"12","author":"JC Birkhoff","year":"2021","unstructured":"Birkhoff JC, Huylebroeck D, Conidi A. ZEB2, the Mowat-Wilson syndrome transcription factor: confirmations, novel functions, and Continuing surprises. Genes (Basel). 2021;12:1037.","journal-title":"Genes (Basel)"},{"key":"604_CR21","doi-asserted-by":"publisher","first-page":"9806","DOI":"10.3390\/ijms24129806","volume":"24","author":"SE Parfenyev","year":"2023","unstructured":"Parfenyev SE, Shabelnikov SV, Tolkunova EN, Barlev NA, Mittenberg AG. p53 affects Zeb1 interactome of breast Cancer stem cells. Int J Mol Sci. 2023;24:9806.","journal-title":"Int J Mol Sci"},{"key":"604_CR22","doi-asserted-by":"publisher","first-page":"928399","DOI":"10.3389\/fmolb.2022.928399","volume":"9","author":"O Semenov","year":"2022","unstructured":"Semenov O, Daks A, Fedorova O, Shuvalov O, Barlev NA. Opposing roles of wild-type and mutant p53 in the process of epithelial to mesenchymal transition. Front Mol Biosci. 2022;9:928399.","journal-title":"Front Mol Biosci"},{"key":"604_CR23","doi-asserted-by":"publisher","first-page":"5295","DOI":"10.1111\/jcmm.16539","volume":"25","author":"L Li","year":"2021","unstructured":"Li L, Feng Y, Hu S, Du Y, Xu X, Zhang M, et al. ZEB1 serves as an oncogene in acute myeloid leukaemia via regulating the PTEN\/PI3K\/AKT signalling pathway by combining with P53. J Cell Mol Med. 2021;25:5295\u2013304.","journal-title":"J Cell Mol Med"},{"key":"604_CR24","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12943-023-01793-z","volume":"22","author":"A Akhmetkaliyev","year":"2023","unstructured":"Akhmetkaliyev A, Alibrahim N, Shafiee D, Tulchinsky E. EMT\/MET plasticity in cancer and Go-or-grow decisions in quiescence: the two sides of the same coin? Mol Cancer. 2023;22:90.","journal-title":"Mol Cancer"},{"key":"604_CR25","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1038\/onc.2016.258","volume":"36","author":"M Rada","year":"2017","unstructured":"Rada M, Vasileva E, Lezina L, Marouco D, Antonov AV, Macip S, et al. Human EHMT2\/G9a activates p53 through methylation-independent mechanism. Oncogene. 2017;36:922\u201332.","journal-title":"Oncogene"},{"key":"604_CR26","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1038\/s41388-018-0566-8","volume":"38","author":"O Fedorova","year":"2019","unstructured":"Fedorova O, Petukhov A, Daks A, Shuvalov O, Leonova T, Vasileva E, et al. Orphan receptor NR4A3 is a novel target of p53 that contributes to apoptosis. Oncogene. 2019;38:2108\u201322.","journal-title":"Oncogene"},{"key":"604_CR27","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/s41420-018-0120-z","volume":"4","author":"E Bulatov","year":"2018","unstructured":"Bulatov E, Sayarova R, Mingaleeva R, Miftakhova R, Gomzikova M, Ignatyev Y, et al. Isatin-Schiff base-copper (II) complex induces cell death in p53-positive tumors. Cell Death Discov. 2018;4:103.","journal-title":"Cell Death Discov"},{"key":"604_CR28","doi-asserted-by":"publisher","first-page":"5197","DOI":"10.1016\/j.bmcl.2017.10.049","volume":"27","author":"TA Grigoreva","year":"2017","unstructured":"Grigoreva TA, Novikova DS, Petukhov AV, Gureev MA, Garabadzhiu AV, Melino G, et al. Proapoptotic modification of substituted isoindolinones as MDM2-p53 inhibitors. Bioorg Med Chem Lett. 2017;27:5197\u2013202.","journal-title":"Bioorg Med Chem Lett"},{"key":"604_CR29","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1182\/blood.2022016362","volume":"141","author":"NG Daver","year":"2023","unstructured":"Daver NG, Dail M, Garcia JS, Jonas BA, Yee KWL, Kelly KR, et al. Venetoclax and idasanutlin in relapsed\/refractory AML: a nonrandomized, open-label phase 1b trial. Blood. 2023;141:1265\u201376.","journal-title":"Blood"},{"key":"604_CR30","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1515\/biol-2016-0033","volume":"11","author":"R Chang","year":"2016","unstructured":"Chang R, Zhang P, You J. Post-translational modifications of EMT transcriptional factors in cancer metastasis. Open Life Sci. 2016;11:237\u201343.","journal-title":"Open Life Sci"},{"key":"604_CR31","doi-asserted-by":"publisher","first-page":"15127","DOI":"10.3390\/ijms232315127","volume":"23","author":"MK Park","year":"2022","unstructured":"Park MK, Lee H, Lee CH. Post-translational modification of ZEB Family members in Cancer Progression. Int J Mol Sci. 2022;23:15127.","journal-title":"Int J Mol Sci"},{"key":"604_CR32","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/ncb3013","volume":"16","author":"P Zhang","year":"2014","unstructured":"Zhang P, Wei Y, Wang L, Debeb BG, Yuan Y, Zhang J, et al. ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1. Nat Cell Biol. 2014;16:864\u201375.","journal-title":"Nat Cell Biol"},{"key":"604_CR33","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41389-019-0125-3","volume":"8","author":"N Li","year":"2019","unstructured":"Li N, Babaei-Jadidi R, Lorenzi F, Spencer-Dene B, Clarke P, Domingo E, et al. An FBXW7-ZEB2 axis links EMT and tumour microenvironment to promote colorectal cancer stem cells and chemoresistance. Oncogenesis. 2019;8:13.","journal-title":"Oncogenesis"},{"key":"604_CR34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/leu.2013.184","volume":"28","author":"JA McCubrey","year":"2014","unstructured":"McCubrey JA, Steelman LS, Bertrand FE, Davis NM, Abrams SL, Montalto G, et al. Multifaceted roles of GSK-3 and Wnt\/\u03b2-catenin in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention. Leukemia. 2014;28:15\u201333.","journal-title":"Leukemia"},{"key":"604_CR35","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s10555-008-9179-y","volume":"28","author":"O Schmalhofer","year":"2009","unstructured":"Schmalhofer O, Brabletz S, Brabletz T. E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer. Cancer Metastasis Rev. 2009;28:151\u201366.","journal-title":"Cancer Metastasis Rev"},{"key":"604_CR36","doi-asserted-by":"publisher","first-page":"925","DOI":"10.3390\/cells10040925","volume":"10","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Liu X, Liang W, Dean DC, Zhang L, Liu Y. Expression and function of ZEB1 in the Cornea. Cells. 2021;10:925.","journal-title":"Cells"},{"key":"604_CR37","doi-asserted-by":"crossref","unstructured":"Scott CL, Omilusik KD, ZEBs. Novel players in Immune Cell development and function. Trends Immunol. 2019;40:431\u201346.","DOI":"10.1016\/j.it.2019.03.001"},{"key":"604_CR38","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/s41418-018-0175-7","volume":"26","author":"L Yao","year":"2019","unstructured":"Yao L, Conforti F, Hill C, Bell J, Drawater L, Li J, et al. Paracrine signalling during ZEB1-mediated epithelial-mesenchymal transition augments local myofibroblast differentiation in lung fibrosis. Cell Death Differ. 2019;26:943\u201357.","journal-title":"Cell Death Differ"},{"key":"604_CR39","doi-asserted-by":"publisher","first-page":"F369","DOI":"10.1152\/ajprenal.00268.2011","volume":"302","author":"M Xiong","year":"2012","unstructured":"Xiong M, Jiang L, Zhou Y, Qiu W, Fang L, Tan R, et al. The miR-200 family regulates TGF-\u03b21-induced renal tubular epithelial to mesenchymal transition through smad pathway by targeting ZEB1 and ZEB2 expression. Am J Physiol Ren Physiol. 2012;302:F369\u2013379.","journal-title":"Am J Physiol Ren Physiol"},{"key":"604_CR40","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.freeradbiomed.2013.10.811","volume":"67","author":"J Wei","year":"2014","unstructured":"Wei J, Zhang Y, Luo Y, Wang Z, Bi S, Song D, et al. Aldose reductase regulates miR-200a-3p\/141-3p to coordinate Keap1-Nrf2, Tgf\u03b21\/2, and Zeb1\/2 signaling in renal mesangial cells and the renal cortex of diabetic mice. Free Radic Biol Med. 2014;67:91\u2013102.","journal-title":"Free Radic Biol Med"},{"key":"604_CR41","doi-asserted-by":"publisher","first-page":"3758","DOI":"10.1074\/jbc.RA117.000295","volume":"293","author":"JG Lee","year":"2018","unstructured":"Lee JG, Jung E, Heur M. Fibroblast growth factor 2 induces proliferation and fibrosis via SNAI1-mediated activation of CDK2 and ZEB1 in corneal endothelium. J Biol Chem. 2018;293:3758\u201369.","journal-title":"J Biol Chem"},{"key":"604_CR42","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1007\/s11010-020-04036-7","volume":"476","author":"L Cheng","year":"2021","unstructured":"Cheng L, Zhou M-Y, Gu Y-J, Chen L, Wang Y. ZEB1: new advances in fibrosis and cancer. Mol Cell Biochem. 2021;476:1643\u201350.","journal-title":"Mol Cell Biochem"},{"key":"604_CR43","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s10735-017-9734-3","volume":"48","author":"Y Li","year":"2017","unstructured":"Li Y, Zhang J, Zhang W, Liu Y, Li Y, Wang K, et al. MicroRNA-192 regulates hypertrophic scar fibrosis by targeting SIP1. J Mol Histol. 2017;48:357\u201366.","journal-title":"J Mol Histol"},{"key":"604_CR44","doi-asserted-by":"publisher","first-page":"3432","DOI":"10.1073\/pnas.0611192104","volume":"104","author":"M Kato","year":"2007","unstructured":"Kato M, Zhang J, Wang M, Lanting L, Yuan H, Rossi JJ, et al. MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Proc Natl Acad Sci U S A. 2007;104:3432\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"604_CR45","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1093\/cvr\/cvab148","volume":"118","author":"W de Haan","year":"2022","unstructured":"de Haan W, Dheedene W, Apelt K, D\u00e9combas-Deschamps S, Vinckier S, Verhulst S, et al. Endothelial Zeb2 preserves the hepatic angioarchitecture and protects against liver fibrosis. Cardiovasc Res. 2022;118:1262\u201375.","journal-title":"Cardiovasc Res"},{"key":"604_CR46","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.3390\/ijms19103207","volume":"19","author":"F Jahan","year":"2018","unstructured":"Jahan F, Landry NM, Rattan SG, Dixon IMC, Wigle JT. The functional role of zinc finger E box-binding homeobox 2 (Zeb2) in promoting Cardiac Fibroblast activation. Int J Mol Sci. 2018;19:3207.","journal-title":"Int J Mol Sci"},{"key":"604_CR47","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/labinvest.2013.108","volume":"93","author":"X Song","year":"2013","unstructured":"Song X, Liu W, Xie S, Wang M, Cao G, Mao C, et al. All-transretinoic acid ameliorates bleomycin-induced lung fibrosis by downregulating the TGF-\u03b21\/Smad3 signaling pathway in rats. Lab Invest. 2013;93:1219\u201331.","journal-title":"Lab Invest"},{"key":"604_CR48","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41419-019-1339-1","volume":"10","author":"W Qian","year":"2019","unstructured":"Qian W, Cai X, Qian Q, Peng W, Yu J, Zhang X, et al. lncRNA ZEB1-AS1 promotes pulmonary fibrosis through ZEB1-mediated epithelial\u2013mesenchymal transition by competitively binding miR-141-3p. Cell Death Dis. 2019;10:129.","journal-title":"Cell Death Dis"},{"key":"604_CR49","doi-asserted-by":"publisher","first-page":"172787","DOI":"10.1016\/j.ejphar.2019.172787","volume":"865","author":"L-Y Li","year":"2019","unstructured":"Li L-Y, Yang C-C, Yang J-F, Li H-D, Zhang B-Y, Zhou H, et al. ZEB1 regulates the activation of hepatic stellate cells through Wnt\/\u03b2-catenin signaling pathway. Eur J Pharmacol. 2019;865:172787.","journal-title":"Eur J Pharmacol"},{"key":"604_CR50","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1247\/csf.28.105","volume":"28","author":"M Sato","year":"2003","unstructured":"Sato M, Suzuki S, Senoo H. Hepatic stellate cells: unique characteristics in cell biology and phenotype. Cell Struct Funct. 2003;28:105\u201312.","journal-title":"Cell Struct Funct"},{"key":"604_CR51","doi-asserted-by":"publisher","first-page":"118147","DOI":"10.1016\/j.lfs.2020.118147","volume":"258","author":"S Hu","year":"2020","unstructured":"Hu S, Liu Y-M, Chen-Chen null, Li L-Y, Zhang B-Y, Yang J-F, et al. MicroRNA-708 prevents ethanol-induced hepatic lipid accumulation and inflammatory reaction via direct targeting ZEB1. Life Sci. 2020;258:118147.","journal-title":"Life Sci"},{"key":"604_CR52","doi-asserted-by":"publisher","first-page":"980","DOI":"10.3389\/fphar.2017.00980","volume":"8","author":"J Yang","year":"2017","unstructured":"Yang J, Liu Q, Cao S, Xu T, Li X, Zhou D, et al. MicroRNA-145 increases the apoptosis of activated hepatic stellate cells Induced by TRAIL through NF-\u03baB signaling pathway. Front Pharmacol. 2017;8:980.","journal-title":"Front Pharmacol"},{"key":"604_CR53","doi-asserted-by":"crossref","unstructured":"Xian S, Chen A, Wu X, Lu C, Wu Y, Huang F, et al. Activation of activin\/Smad2 and 3 signaling pathway and the potential involvement of endothelial\u2013mesenchymal transition in the valvular damage due to rheumatic heart disease. Mol Med Rep. 2021;23:10.","DOI":"10.3892\/mmr.2020.11648"},{"key":"604_CR54","doi-asserted-by":"publisher","first-page":"121465","DOI":"10.1016\/j.biomaterials.2022.121465","volume":"283","author":"S-C Tao","year":"2022","unstructured":"Tao S-C, Li X-R, Wei W-J, Wei Z-Y, Zhang C-R, Wang F, et al. Polymeric coating on \u03b2-TCP scaffolds provides immobilization of small extracellular vesicles with surface-functionalization and ZEB1-Loading for bone defect repair in diabetes mellitus. Biomaterials. 2022;283:121465.","journal-title":"Biomaterials"},{"key":"604_CR55","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1093\/jb\/mvaa011","volume":"167","author":"Z Zhai","year":"2020","unstructured":"Zhai Z, Chen W, Hu Q, Wang X, Zhao Q, Tuerxunyiming M. High glucose inhibits osteogenic differentiation of bone marrow mesenchymal stem cells via regulating miR-493-5p\/ZEB2 signalling. J Biochem. 2020;167:613\u201321.","journal-title":"J Biochem"},{"key":"604_CR56","doi-asserted-by":"crossref","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67:7\u201330.","DOI":"10.3322\/caac.21387"},{"key":"604_CR57","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1158\/0008-5472.CAN-17-2476","volume":"78","author":"J Caramel","year":"2018","unstructured":"Caramel J, Ligier M, Puisieux A. Pleiotropic roles for ZEB1 in Cancer. Cancer Res. 2018;78:30\u20135.","journal-title":"Cancer Res"},{"key":"604_CR58","first-page":"748","volume":"5","author":"X Yang","year":"2015","unstructured":"Yang X, Li L, Huang Q, Xu W, Cai X, Zhang J, et al. Wnt signaling through Snail1 and Zeb1 regulates bone metastasis in lung cancer. Am J Cancer Res. 2015;5:748\u201355.","journal-title":"Am J Cancer Res"},{"key":"604_CR59","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.3892\/ijo_00000304","volume":"34","author":"M Katoh","year":"2009","unstructured":"Katoh M, Katoh M. Integrative genomic analyses of ZEB2: transcriptional regulation of ZEB2 based on SMADs, ETS1, HIF1alpha, POU\/OCT, and NF-kappaB. Int J Oncol. 2009;34:1737\u201342.","journal-title":"Int J Oncol"},{"issue":"Suppl 3","key":"604_CR60","doi-asserted-by":"publisher","first-page":"S656","DOI":"10.1245\/s10434-012-2217-6","volume":"19","author":"J Kurashige","year":"2012","unstructured":"Kurashige J, Kamohara H, Watanabe M, Hiyoshi Y, Iwatsuki M, Tanaka Y, et al. MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma. Ann Surg Oncol. 2012;19(Suppl 3):S656\u2013664.","journal-title":"Ann Surg Oncol"},{"key":"604_CR61","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/nature14897","volume":"525","author":"X Ye","year":"2015","unstructured":"Ye X, Tam WL, Shibue T, Kaygusuz Y, Reinhardt F, Ng Eaton E, et al. Distinct EMT programs control normal mammary stem cells and tumour-initiating cells. Nature. 2015;525:256\u201360.","journal-title":"Nature"},{"key":"604_CR62","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrclinonc.2017.44","volume":"14","author":"T Shibue","year":"2017","unstructured":"Shibue T, Weinberg RA. EMT, CSCs, and drug resistance: the mechanistic link and clinical implications. Nat Rev Clin Oncol. 2017;14:611\u201329.","journal-title":"Nat Rev Clin Oncol"},{"key":"604_CR63","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1002\/jso.23012","volume":"105","author":"A Shen","year":"2012","unstructured":"Shen A, Zhang Y, Yang H, Xu R, Huang G. Overexpression of ZEB1 relates to metastasis and invasion in osteosarcoma. J Surg Oncol. 2012;105:830\u20134.","journal-title":"J Surg Oncol"},{"key":"604_CR64","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1002\/1878-0261.12965","volume":"15","author":"R Sreekumar","year":"2021","unstructured":"Sreekumar R, Al-Saihati H, Emaduddin M, Moutasim K, Mellone M, Patel A, et al. The ZEB2-dependent EMT transcriptional programme drives therapy resistance by activating nucleotide excision repair genes ERCC1 and ERCC4 in colorectal cancer. Mol Oncol. 2021;15:2065\u201383.","journal-title":"Mol Oncol"},{"key":"604_CR65","doi-asserted-by":"publisher","first-page":"3823","DOI":"10.1038\/sj.onc.1203721","volume":"19","author":"ML Grooteclaes","year":"2000","unstructured":"Grooteclaes ML, Frisch SM. Evidence for a function of CtBP in epithelial gene regulation and anoikis. Oncogene. 2000;19:3823\u20138.","journal-title":"Oncogene"},{"key":"604_CR66","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1038\/sj.bjc.6601685","volume":"90","author":"A Miyoshi","year":"2004","unstructured":"Miyoshi A, Kitajima Y, Sumi K, Sato K, Hagiwara A, Koga Y, et al. Snail and SIP1 increase cancer invasion by upregulating MMP family in hepatocellular carcinoma cells. Br J Cancer. 2004;90:1265\u201373.","journal-title":"Br J Cancer"},{"key":"604_CR67","doi-asserted-by":"publisher","first-page":"6979","DOI":"10.1038\/sj.onc.1210508","volume":"26","author":"K Aigner","year":"2007","unstructured":"Aigner K, Dampier B, Descovich L, Mikula M, Sultan A, Schreiber M, et al. The transcription factor ZEB1 (\u03b4EF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity. Oncogene. 2007;26:6979\u201388.","journal-title":"Oncogene"},{"key":"604_CR68","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/embor.2010.117","volume":"11","author":"S Brabletz","year":"2010","unstructured":"Brabletz S, Brabletz T. The ZEB\/miR-200 feedback loop\u2013a motor of cellular plasticity in development and cancer? EMBO Rep. 2010;11:670\u20137.","journal-title":"EMBO Rep"},{"key":"604_CR69","doi-asserted-by":"publisher","first-page":"6566","DOI":"10.1093\/nar\/gki965","volume":"33","author":"C Vandewalle","year":"2005","unstructured":"Vandewalle C, Comijn J, De Craene B, Vermassen P, Bruyneel E, Andersen H, et al. SIP1\/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions. Nucleic Acids Res. 2005;33:6566\u201378.","journal-title":"Nucleic Acids Res"},{"key":"604_CR70","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1038\/sj.bjc.6601685","volume":"90","author":"A Miyoshi","year":"2004","unstructured":"Miyoshi A, Kitajima Y, Sumi K, Sato K, Hagiwara A, Koga Y, et al. Snail and SIP1 increase cancer invasion by upregulating MMP family in hepatocellular carcinoma cells. Br J Cancer. 2004;90:1265.","journal-title":"Br J Cancer"},{"key":"604_CR71","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.oraloncology.2012.07.012","volume":"49","author":"P-Y Chu","year":"2013","unstructured":"Chu P-Y, Hu F-W, Yu C-C, Tsai L-L, Yu C-H, Wu B-C, et al. Epithelial-mesenchymal transition transcription factor ZEB1\/ZEB2 co-expression predicts poor prognosis and maintains tumor-initiating properties in head and neck cancer. Oral Oncol. 2013;49:34\u201341.","journal-title":"Oral Oncol"},{"key":"604_CR72","first-page":"1758","volume":"16","author":"K Suzuki","year":"2018","unstructured":"Suzuki K, Kawataki T, Endo K, Miyazawa K, Kinouchi H, Saitoh M. Expression of ZEBs in gliomas is associated with invasive properties and histopathological grade. Oncol Lett. 2018;16:1758\u201364.","journal-title":"Oncol Lett"},{"key":"604_CR73","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12943-017-0711-y","volume":"16","author":"W Su","year":"2017","unstructured":"Su W, Xu M, Chen X, Chen N, Gong J, Nie L, et al. Long noncoding RNA ZEB1-AS1 epigenetically regulates the expressions of ZEB1 and downstream molecules in prostate cancer. Mol Cancer. 2017;16:142.","journal-title":"Mol Cancer"},{"key":"604_CR74","doi-asserted-by":"publisher","first-page":"4176","DOI":"10.1002\/jcb.29572","volume":"121","author":"N Luo","year":"2020","unstructured":"Luo N, Zhang K, Li X, Hu Y. ZEB1 induced-upregulation of long noncoding RNA ZEB1-AS1 facilitates the progression of triple negative breast cancer by binding with ELAVL1 to maintain the stability of ZEB1 mRNA. J Cell Biochem. 2020;121:4176\u201387.","journal-title":"J Cell Biochem"},{"key":"604_CR75","doi-asserted-by":"publisher","first-page":"4269","DOI":"10.1111\/jcmm.14318","volume":"23","author":"P Diao","year":"2019","unstructured":"Diao P, Ge H, Song Y, Wu Y, Li J, Li Z, et al. Overexpression of ZEB2-AS1 promotes epithelial-to-mesenchymal transition and metastasis by stabilizing ZEB2 mRNA in head neck squamous cell carcinoma. J Cell Mol Med. 2019;23:4269\u201380.","journal-title":"J Cell Mol Med"},{"key":"604_CR76","doi-asserted-by":"publisher","first-page":"e32838","DOI":"10.1371\/journal.pone.0032838","volume":"7","author":"M-Y Cai","year":"2012","unstructured":"Cai M-Y, Luo R-Z, Chen J-W, Pei X-Q, Lu J-B, Hou J-H, et al. Overexpression of ZEB2 in peritumoral liver tissue correlates with favorable survival after curative resection of hepatocellular carcinoma. PLoS ONE. 2012;7:e32838.","journal-title":"PLoS ONE"},{"key":"604_CR77","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1245\/s10434-011-1772-6","volume":"19","author":"Y-M Zhou","year":"2012","unstructured":"Zhou Y-M, Cao L, Li B, Zhang R-X, Sui C-J, Yin Z-F, et al. Clinicopathological significance of ZEB1 protein in patients with hepatocellular carcinoma. Ann Surg Oncol. 2012;19:1700\u20136.","journal-title":"Ann Surg Oncol"},{"key":"604_CR78","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1186\/1471-2407-13-572","volume":"13","author":"M Hashiguchi","year":"2013","unstructured":"Hashiguchi M, Ueno S, Sakoda M, Iino S, Hiwatashi K, Minami K, et al. Clinical implication of ZEB-1 and E-cadherin expression in hepatocellular carcinoma (HCC). BMC Cancer. 2013;13:572.","journal-title":"BMC Cancer"},{"key":"604_CR79","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1007\/s10620-012-2042-6","volume":"57","author":"Y-H Dai","year":"2012","unstructured":"Dai Y-H, Tang Y-P, Zhu H-Y, Lv L, Chu Y, Zhou Y-Q, et al. ZEB2 promotes the metastasis of gastric cancer and modulates epithelial mesenchymal transition of gastric cancer cells. Dig Dis Sci. 2012;57:1253\u201360.","journal-title":"Dig Dis Sci"},{"key":"604_CR80","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1002\/jso.23564","volume":"109","author":"T Murai","year":"2014","unstructured":"Murai T, Yamada S, Fuchs BC, Fujii T, Nakayama G, Sugimoto H, et al. Epithelial-to-mesenchymal transition predicts prognosis in clinical gastric cancer. J Surg Oncol. 2014;109:684\u20139.","journal-title":"J Surg Oncol"},{"key":"604_CR81","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1002\/jso.22142","volume":"106","author":"Y Okugawa","year":"2012","unstructured":"Okugawa Y, Toiyama Y, Tanaka K, Matsusita K, Fujikawa H, Saigusa S, et al. Clinical significance of zinc finger E-box binding homeobox 1 (ZEB1) in human gastric cancer. J Surg Oncol. 2012;106:280\u20135.","journal-title":"J Surg Oncol"},{"key":"604_CR82","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.2147\/OTT.S163570","volume":"11","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Lin S, Chen Y, Yang F, Liu S. LDH-Apromotes epithelial-mesenchymal transition by upregulating ZEB2 in intestinal-type gastric cancer. Onco Targets Ther. 2018;11:2363\u201373.","journal-title":"Onco Targets Ther"},{"key":"604_CR83","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1038\/sj.onc.1210012","volume":"26","author":"Y Imamichi","year":"2007","unstructured":"Imamichi Y, K\u00f6nig A, Gress T, Menke A. Collagen type I-induced smad-interacting protein 1 expression downregulates E-cadherin in pancreatic cancer. Oncogene. 2007;26:2381\u20135.","journal-title":"Oncogene"},{"key":"604_CR84","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.surg.2014.02.018","volume":"156","author":"P Bronsert","year":"2014","unstructured":"Bronsert P, Kohler I, Timme S, Kiefer S, Werner M, Schilling O, et al. Prognostic significance of zinc finger E-box binding homeobox 1 (ZEB1) expression in cancer cells and cancer-associated fibroblasts in pancreatic head cancer. Surgery. 2014;156:97\u2013108.","journal-title":"Surgery"},{"key":"604_CR85","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1002\/jso.23020","volume":"105","author":"H Kurahara","year":"2012","unstructured":"Kurahara H, Takao S, Maemura K, Mataki Y, Kuwahata T, Maeda K, et al. Epithelial-mesenchymal transition and mesenchymal-epithelial transition via regulation of ZEB-1 and ZEB-2 expression in pancreatic cancer. J Surg Oncol. 2012;105:655\u201361.","journal-title":"J Surg Oncol"},{"key":"604_CR86","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.ejca.2009.12.014","volume":"46","author":"J Ferlay","year":"2010","unstructured":"Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer. 2010;46:765\u201381.","journal-title":"Eur J Cancer"},{"key":"604_CR87","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/nm.3967","volume":"21","author":"J Guinney","year":"2015","unstructured":"Guinney J, Dienstmann R, Wang X, de Reyni\u00e8s A, Schlicker A, Soneson C, et al. The consensus molecular subtypes of colorectal cancer. Nat Med. 2015;21:1350\u20136.","journal-title":"Nat Med"},{"key":"604_CR88","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1053\/j.gastro.2011.08.038","volume":"141","author":"AB Singh","year":"2011","unstructured":"Singh AB, Sharma A, Smith JJ, Krishnan M, Chen X, Eschrich S, et al. Claudin-1 up-regulates the repressor ZEB-1 to inhibit E-cadherin expression in colon cancer cells. Gastroenterology. 2011;141:2140\u201353.","journal-title":"Gastroenterology"},{"key":"604_CR89","doi-asserted-by":"publisher","first-page":"7654","DOI":"10.1158\/1078-0432.CCR-10-2816","volume":"17","author":"C Kahlert","year":"2011","unstructured":"Kahlert C, Lahes S, Radhakrishnan P, Dutta S, Mogler C, Herpel E, et al. Overexpression of ZEB2 at the invasion front of colorectal cancer is an independent prognostic marker and regulates tumor invasion in vitro. Clin Cancer Res. 2011;17:7654\u201363.","journal-title":"Clin Cancer Res"},{"key":"604_CR90","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1016\/j.juro.2011.02.059","volume":"185","author":"SP Kim","year":"2011","unstructured":"Kim SP, Alt AL, Weight CJ, Costello BA, Cheville JC, Lohse C, et al. Independent validation of the 2010 American Joint Committee on Cancer TNM classification for renal cell carcinoma: results from a large, single institution cohort. J Urol. 2011;185:2035\u20139.","journal-title":"J Urol"},{"key":"604_CR91","doi-asserted-by":"publisher","first-page":"e62558","DOI":"10.1371\/journal.pone.0062558","volume":"8","author":"Y Fang","year":"2013","unstructured":"Fang Y, Wei J, Cao J, Zhao H, Liao B, Qiu S, et al. Protein expression of ZEB2 in renal cell carcinoma and its prognostic significance in patient survival. PLoS ONE. 2013;8:e62558.","journal-title":"PLoS ONE"},{"key":"604_CR92","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1159\/000445752","volume":"83","author":"M Sugimoto","year":"2016","unstructured":"Sugimoto M, Kohashi K, Itsumi M, Shiota M, Abe T, Yamada Y, et al. Epithelial to Mesenchymal Transition in Clear Cell Renal Cell Carcinoma with Rhabdoid features. Pathobiology. 2016;83:277\u201386.","journal-title":"Pathobiology"},{"key":"604_CR93","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1002\/cncr.20946","volume":"103","author":"S Elloul","year":"2005","unstructured":"Elloul S, Elstrand MB, Nesland JM, Trop\u00e9 CG, Kvalheim G, Goldberg I, et al. Snail, slug, and smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma. Cancer. 2005;103:1631\u201343.","journal-title":"Cancer"},{"key":"604_CR94","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1097\/IGC.0000000000001037","volume":"27","author":"Z Yan","year":"2017","unstructured":"Yan Z, Tian X, Wang R, Cheng X, Mi J, Xiong L, et al. Title prognosis significance of ZEB2 and TGF-\u03b21 as well as other clinical characteristics in epithelial ovarian Cancer. Int J Gynecol Cancer. 2017;27:1343\u20139.","journal-title":"Int J Gynecol Cancer"},{"key":"604_CR95","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.18632\/oncotarget.1463","volume":"4","author":"G-Y Bae","year":"2013","unstructured":"Bae G-Y, Choi S-J, Lee J-S, Jo J, Lee J, Kim J, et al. Loss of E-cadherin activates EGFR-MEK\/ERK signaling, which promotes invasion via the ZEB1\/MMP2 axis in non-small cell lung cancer. Oncotarget. 2013;4:2512\u201322.","journal-title":"Oncotarget"},{"key":"604_CR96","doi-asserted-by":"publisher","first-page":"5241","DOI":"10.1038\/ncomms6241","volume":"5","author":"L Chen","year":"2014","unstructured":"Chen L, Gibbons DL, Goswami S, Cortez MA, Ahn Y-H, Byers LA, et al. Metastasis is regulated via microRNA-200\/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression. Nat Commun. 2014;5:5241.","journal-title":"Nat Commun"},{"key":"604_CR97","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1172\/JCI72171","volume":"124","author":"Y Yang","year":"2014","unstructured":"Yang Y, Ahn Y-H, Chen Y, Tan X, Guo L, Gibbons DL, et al. ZEB1 sensitizes lung adenocarcinoma to metastasis suppression by PI3K antagonism. J Clin Invest. 2014;124:2696\u2013708.","journal-title":"J Clin Invest"},{"key":"604_CR98","doi-asserted-by":"publisher","first-page":"12231","DOI":"10.1038\/ncomms12231","volume":"7","author":"T Zhang","year":"2016","unstructured":"Zhang T, Guo L, Creighton CJ, Lu Q, Gibbons DL, Yi ES, et al. A genetic cell context-dependent role for ZEB1 in lung cancer. Nat Commun. 2016;7:12231.","journal-title":"Nat Commun"},{"key":"604_CR99","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1200\/JCO.2012.43.0454","volume":"31","author":"PJ Roberts","year":"2013","unstructured":"Roberts PJ, Stinchcombe TE. KRAS mutation: should we test for it, and does it matter? J Clin Oncol. 2013;31:1112\u201321.","journal-title":"J Clin Oncol"},{"key":"604_CR100","doi-asserted-by":"publisher","first-page":"111452","DOI":"10.1016\/j.celrep.2022.111452","volume":"41","author":"Y Guo","year":"2022","unstructured":"Guo Y, Lu X, Chen Y, Clark G, Trent J, Cuatrecasas M, et al. Opposing roles of ZEB1 in the cytoplasm and nucleus control cytoskeletal assembly and YAP1 activity. Cell Rep. 2022;41:111452.","journal-title":"Cell Rep"},{"key":"604_CR101","doi-asserted-by":"crossref","unstructured":"Larsen JE, Nathan V, Osborne JK, Farrow RK, Deb D, Sullivan JP et al. ZEB1 drives epithelial-to-mesenchymal transition in lung cancer. J Clin Invest. 2016;126:3219\u201335.","DOI":"10.1172\/JCI76725"},{"key":"604_CR102","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s11033-012-2136-4","volume":"40","author":"J Zhang","year":"2013","unstructured":"Zhang J, Lu C, Zhang J, Kang J, Cao C, Li M. Involvement of ZEB1 and E-cadherin in the invasion of lung squamous cell carcinoma. Mol Biol Rep. 2013;40:949\u201356.","journal-title":"Mol Biol Rep"},{"key":"604_CR103","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.ogc.2021.11.010","volume":"49","author":"VF Grabinski","year":"2022","unstructured":"Grabinski VF, Brawley OW. Disparities in breast Cancer. Obstet Gynecol Clin North Am. 2022;49:149\u201365.","journal-title":"Obstet Gynecol Clin North Am"},{"key":"604_CR104","doi-asserted-by":"publisher","first-page":"e103209","DOI":"10.15252\/embj.2019103209","volume":"39","author":"N Feldker","year":"2020","unstructured":"Feldker N, Ferrazzi F, Schuhwerk H, Widholz SA, Guenther K, Frisch I, et al. Genome-wide cooperation of EMT transcription factor ZEB1 with YAP and AP\u20101 in breast cancer. EMBO J. 2020;39:e103209.","journal-title":"EMBO J"},{"key":"604_CR105","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/nm.4323","volume":"23","author":"A-P Morel","year":"2017","unstructured":"Morel A-P, Ginestier C, Pommier RM, Cabaud O, Ruiz E, Wicinski J, et al. A stemness-related ZEB1-MSRB3 axis governs cellular pliancy and breast cancer genome stability. Nat Med. 2017;23:568\u201378.","journal-title":"Nat Med"},{"key":"604_CR106","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1038\/s41467-022-29723-5","volume":"13","author":"N Mohammadi Ghahhari","year":"2022","unstructured":"Mohammadi Ghahhari N, Sznurkowska MK, Hulo N, Bernasconi L, Aceto N, Picard D. Cooperative interaction between ER\u03b1 and the EMT-inducer ZEB1 reprograms breast cancer cells for bone metastasis. Nat Commun. 2022;13:2104.","journal-title":"Nat Commun"},{"key":"604_CR107","doi-asserted-by":"publisher","first-page":"6245","DOI":"10.3390\/curroncol29090491","volume":"29","author":"RJ Stubbins","year":"2022","unstructured":"Stubbins RJ, Francis A, Kuchenbauer F, Sanford D. Management of Acute myeloid leukemia: a review for General practitioners in Oncology. Curr Oncol. 2022;29:6245\u201359.","journal-title":"Curr Oncol"},{"key":"604_CR108","doi-asserted-by":"crossref","unstructured":"Almotiri A, Alzahrani H, Menendez-Gonzalez JB, Abdelfattah A, Alotaibi B, Saleh L et al. Zeb1 modulates hematopoietic stem cell fates required for suppressing acute myeloid leukemia. J Clin Invest. 2021;131:e129115.","DOI":"10.1172\/JCI129115"},{"key":"604_CR109","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1084\/jem.20171352","volume":"215","author":"T Guan","year":"2018","unstructured":"Guan T, Dominguez CX, Amezquita RA, Laidlaw BJ, Cheng J, Henao-Mejia J, et al. ZEB1, ZEB2, and the miR-200 family form a counterregulatory network to regulate CD8\u2009+\u2009T cell fates. J Exp Med. 2018;215:1153\u201368.","journal-title":"J Exp Med"},{"key":"604_CR110","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1182\/blood-2008-01-131185","volume":"112","author":"T Hidaka","year":"2008","unstructured":"Hidaka T, Nakahata S, Hatakeyama K, Hamasaki M, Yamashita K, Kohno T, et al. Down-regulation of TCF8 is involved in the leukemogenesis of adult T-cell leukemia\/lymphoma. Blood. 2008;112:383\u201393.","journal-title":"Blood"},{"key":"604_CR111","doi-asserted-by":"publisher","first-page":"4157","DOI":"10.1038\/onc.2010.172","volume":"29","author":"S Nakahata","year":"2010","unstructured":"Nakahata S, Yamazaki S, Nakauchi H, Morishita K. Downregulation of ZEB1 and overexpression of Smad7 contribute to resistance to TGF-beta1-mediated growth suppression in adult T-cell leukemia\/lymphoma. Oncogene. 2010;29:4157\u201369.","journal-title":"Oncogene"},{"key":"604_CR112","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/cdd.2013.123","volume":"21","author":"E S\u00e1nchez-Till\u00f3","year":"2014","unstructured":"S\u00e1nchez-Till\u00f3 E, Fanlo L, Siles L, Montes-Moreno S, Moros A, Chiva-Blanch G, et al. The EMT activator ZEB1 promotes tumor growth and determines differential response to chemotherapy in mantle cell lymphoma. Cell Death Differ. 2014;21:247\u201357.","journal-title":"Cell Death Differ"},{"key":"604_CR113","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1182\/blood-2016-05-714659","volume":"129","author":"J Li","year":"2017","unstructured":"Li J, Riedt T, Goossens S, Carrillo Garc\u00eda C, Szczepanski S, Brandes M, et al. The EMT transcription factor Zeb2 controls adult murine hematopoietic differentiation by regulating cytokine signaling. Blood. 2017;129:460\u201372.","journal-title":"Blood"},{"key":"604_CR114","doi-asserted-by":"publisher","first-page":"147782","DOI":"10.1016\/j.brainres.2022.147782","volume":"1778","author":"Y Sun","year":"2022","unstructured":"Sun Y, Jiang Y, Wang Y, Yu P, Su X, Song Y, et al. The epithelial-mesenchymal transition of glioma cells promotes tissue factor expression via the miR200a\/ZEB1 axis. Brain Res. 2022;1778:147782.","journal-title":"Brain Res"},{"key":"604_CR115","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s11060-016-2240-8","volume":"130","author":"CL Nesvick","year":"2016","unstructured":"Nesvick CL, Zhang C, Edwards NA, Montgomery BK, Lee M, Yang C, et al. ZEB1 expression is increased in IDH1-mutant lower-grade gliomas. J Neurooncol. 2016;130:111\u201322.","journal-title":"J Neurooncol"},{"key":"604_CR116","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41416-020-01048-4","volume":"124","author":"H Raskov","year":"2021","unstructured":"Raskov H, Orhan A, Christensen JP, G\u00f6genur I. Cytotoxic CD8\u2009+\u2009T cells in cancer and cancer immunotherapy. Br J Cancer. 2021;124:359\u201367.","journal-title":"Br J Cancer"},{"key":"604_CR117","doi-asserted-by":"publisher","first-page":"4669","DOI":"10.1158\/1078-0432.CCR-20-4459","volume":"27","author":"M Taki","year":"2021","unstructured":"Taki M, Abiko K, Ukita M, Murakami R, Yamanoi K, Yamaguchi K, et al. Tumor Immune Microenvironment during epithelial-mesenchymal transition. Clin Cancer Res. 2021;27:4669\u201379.","journal-title":"Clin Cancer Res"},{"key":"604_CR118","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3389\/fphys.2014.00075","volume":"5","author":"V Riabov","year":"2014","unstructured":"Riabov V, Gudima A, Wang N, Mickley A, Orekhov A, Kzhyshkowska J. Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis. Front Physiol. 2014;5:75.","journal-title":"Front Physiol"},{"key":"604_CR119","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.it.2015.02.004","volume":"36","author":"R Ostuni","year":"2015","unstructured":"Ostuni R, Kratochvill F, Murray PJ, Natoli G. Macrophages and cancer: from mechanisms to therapeutic implications. Trends Immunol. 2015;36:229\u201339.","journal-title":"Trends Immunol"},{"key":"604_CR120","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/ncb3041","volume":"16","author":"H Lu","year":"2014","unstructured":"Lu H, Clauser KR, Tam WL, Fr\u00f6se J, Ye X, Eaton EN, et al. A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages. Nat Cell Biol. 2014;16:1105\u201317.","journal-title":"Nat Cell Biol"},{"key":"604_CR121","doi-asserted-by":"publisher","first-page":"113490","DOI":"10.1016\/j.biopha.2022.113490","volume":"153","author":"J Lu","year":"2022","unstructured":"Lu J, Fei F, Wu C, Mei J, Xu J, Lu P. ZEB1: Catalyst of immune escape during tumor metastasis. Biomed Pharmacother. 2022;153:113490.","journal-title":"Biomed Pharmacother"},{"key":"604_CR122","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.15252\/embj.201797345","volume":"36","author":"M Cort\u00e9s","year":"2017","unstructured":"Cort\u00e9s M, Sanchez-Moral L, de Barrios O, Fern\u00e1ndez-Ace\u00f1ero MJ, Mart\u00ednez-Campanario MC, Esteve-Codina A, et al. Tumor-associated macrophages (TAMs) depend on ZEB1 for their cancer-promoting roles. EMBO J. 2017;36:3336\u201355.","journal-title":"EMBO J"},{"key":"604_CR123","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41419-019-1748-1","volume":"10","author":"X-J Chen","year":"2019","unstructured":"Chen X-J, Deng Y-R, Wang Z-C, Wei W-F, Zhou C-F, Zhang Y-M, et al. Hypoxia-induced ZEB1 promotes cervical cancer progression via CCL8-dependent tumour-associated macrophage recruitment. Cell Death Dis. 2019;10:508.","journal-title":"Cell Death Dis"},{"key":"604_CR124","doi-asserted-by":"publisher","first-page":"e003484","DOI":"10.1136\/jitc-2021-003484","volume":"10","author":"M Plaschka","year":"2022","unstructured":"Plaschka M, Benboubker V, Grimont M, Berthet J, Tonon L, Lopez J, et al. ZEB1 transcription factor promotes immune escape in melanoma. J Immunother Cancer. 2022;10:e003484.","journal-title":"J Immunother Cancer"},{"key":"604_CR125","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.3390\/cancers12103076","volume":"12","author":"E Karamitopoulou","year":"2020","unstructured":"Karamitopoulou E. The Tumor Microenvironment of Pancreatic Cancer. Cancers (Basel). 2020;12:3076.","journal-title":"Cancers (Basel)"},{"key":"604_CR126","doi-asserted-by":"crossref","unstructured":"Wang J, Lu B, Zeng S, Kong F, Li L, Zhuo H et al. The dual role of ZEB2 in COAD metastasis and immunology [Internet]. 2022 [cited 2024 Nov 7]. Available from: https:\/\/www.researchsquare.com\/article\/rs-2031323\/v1","DOI":"10.21203\/rs.3.rs-2031323\/v1"},{"key":"604_CR127","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/nri.2017.105","volume":"18","author":"V Papayannopoulos","year":"2018","unstructured":"Papayannopoulos V. Neutrophil extracellular traps in immunity and disease. Nat Rev Immunol. 2018;18:134\u201347.","journal-title":"Nat Rev Immunol"},{"key":"604_CR128","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1038\/modpathol.2008.82","volume":"21","author":"M Singh","year":"2008","unstructured":"Singh M, Spoelstra NS, Jean A, Howe E, Torkko KC, Clark HR, et al. ZEB1 expression in type I vs type II endometrial cancers: a marker of aggressive disease. Mod Pathol. 2008;21:912\u201323.","journal-title":"Mod Pathol"},{"key":"604_CR129","first-page":"3370","volume":"10","author":"M Ouled Dhaou","year":"2020","unstructured":"Ouled Dhaou M, Kossai M, Morel A-P, Devouassoux-Shisheboran M, Puisieux A, Penault-Llorca F, et al. Zeb1 expression by tumor or stromal cells is associated with spatial distribution patterns of CD8\u2009+\u2009tumor-infiltrating lymphocytes: a hypothesis-generating study on 113 triple negative breast cancers. Am J Cancer Res. 2020;10:3370\u201381.","journal-title":"Am J Cancer Res"},{"key":"604_CR130","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41419-020-03327-7","volume":"12","author":"S Parfenyev","year":"2021","unstructured":"Parfenyev S, Singh A, Fedorova O, Daks A, Kulshreshtha R, Barlev NA. Interplay between p53 and non-coding RNAs in the regulation of EMT in breast cancer. Cell Death Dis. 2021;12:17.","journal-title":"Cell Death Dis"},{"key":"604_CR131","doi-asserted-by":"publisher","first-page":"4615","DOI":"10.1091\/mbc.e07-05-0406","volume":"18","author":"J Mejlvang","year":"2007","unstructured":"Mejlvang J, Kriajevska M, Vandewalle C, Chernova T, Sayan AE, Berx G, et al. Direct repression of cyclin D1 by SIP1 attenuates cell cycle progression in cells undergoing an epithelial mesenchymal transition. Mol Biol Cell. 2007;18:4615\u201324.","journal-title":"Mol Biol Cell"},{"key":"604_CR132","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/j.humpath.2015.05.010","volume":"46","author":"MH Jang","year":"2015","unstructured":"Jang MH, Kim HJ, Kim EJ, Chung YR, Park SY. Expression of epithelial-mesenchymal transition-related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome. Hum Pathol. 2015;46:1267\u201374.","journal-title":"Hum Pathol"}],"container-title":["Biology Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-025-00604-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13062-025-00604-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-025-00604-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T15:05:31Z","timestamp":1742569531000},"score":1,"resource":{"primary":{"URL":"https:\/\/biologydirect.biomedcentral.com\/articles\/10.1186\/s13062-025-00604-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,20]]},"references-count":132,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["604"],"URL":"https:\/\/doi.org\/10.1186\/s13062-025-00604-3","relation":{},"ISSN":["1745-6150"],"issn-type":[{"value":"1745-6150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,20]]},"assertion":[{"value":"24 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32"}}